Sandpiper22
Posted - 8 hours ago
$PRME say goodbye to sub $5
Stock_Titan
Posted - 18 hours ago
$PRME Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference
https://www.stocktitan.net/news/PRME/prime-medicine-to-participate-in-the-27th-annual-milken-institute-v04gdfr2bw5i.html
piku99
Posted - 04/30/24
$PRME fanfare of $20 to below 4, slowly and steadily!!
Sandpiper22
Posted - 04/29/24
$CRBU XBI and small caps roaring...have a day $PRME congrats on the IND clearance.
Etrading
Posted - 04/29/24
$PRME today news is good and no volume yet here i loaded and will wait for RUN ... $spy $sofi $tsla $arkk
Etrading
Posted - 04/29/24
Not sure what i must be more excited about? for my $tsla call? or huge $rxrx share from dips? or $sofi took profit while people in big fomo; or added back some $prme at today pulls or $amzn call (that is nothing now)
Etrading
Posted - 04/29/24
$rxrx $8.40 is the key for breakout .. but I am not in hurry since I want to add more !! $prme got back on this one too after today good news $sofi $tsla
DonCorleone77
Posted - 04/29/24
$PRME Prime Medicine announces FDA clearance of IND application for PM359 Prime Medicine announced that the U.S. Food and Drug Administration, FDA, has cleared the company's Investigational New Drug, IND, application for PM359, submitted on March 29, for the treatment of chronic granulomatous disease, CGD, enabling the Company to initiate its global Phase 1/2 clinical trial in the United States. "We are thrilled to achieve this important milestone for our first product candidate, PM359, which represents the first-ever IND clearance for a Prime Editor product candidate and a significant advancement in the field of next-generation gene editing," said Keith Gottesdiener, M.D., President and Chief Executive Officer of Prime Medicine. "Based on data from our preclinical studies, we believe PM359 has the potential to sufficiently correct a prevalent disease-causing mutation of CGD, leading to amelioration of disease for these patients. We look forward to the planned initiation of our Phase 1/2 trial and further determining the potential therapeutic impact of PM359 in patients with this devastating disease."
Stock_Titan
Posted - 04/29/24
$PRME Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
https://www.stocktitan.net/news/PRME/prime-medicine-announces-fda-clearance-of-investigational-new-drug-9xlmejd9obu0.html
Sandpiper22
Posted - 04/27/24
$PRME flipping under $5 is fun…won’t last long though 📈
Etrading
Posted - 04/26/24
$roku and $intc soon buy the dips will be; not yet.. meanwhile adding more $sofi $rxrx at this dips even $prme stupidly low
Etrading
Posted - 04/25/24
$PRME MC only 500M and too many upgrade recently !! i ll add some for quick swing for a few days hold... my $meta 400-410 add alert worked well for quick swing $tsla too strong... BUY THE RUMOR 8/8/2024 ROBOTAXI-AI etc pump $spy
MagisterofMarkets
Posted - 04/25/24
$PRME $CRBU $VERV $BEAM $NTLA cant stop buying, I guess I’m a sucker for pain
Sandpiper22
Posted - 04/24/24
$PRME buying more tomorrow.
Etrading
Posted - 04/24/24
$rxrx and $prme and $sofi giving nice dips at open to buy back $TSLA option burn at open !!!
Etrading
Posted - 04/23/24
Bears 🐻 will be scare after $NVDA earning for $RXRX !! This will be way better than $TSLA .. Plus $prme .. Thank me later like last time rxrx 14-15 pump $SPY
Sandpiper22
Posted - 04/23/24
$PRME just your casual AH purchase of 99,973 shares @ $5.00 (time stamp of 5:38 pm ET)
Etrading
Posted - 04/23/24
$prme stupid seller selling my prme and $rxrx just like they did my $sofi yesterday at 7.10 but those bears quite at sofi now... screw your games- i buy more even over buy at every pulls-- instead OVERBNOUGHT MAG7 i buy these. $spy $tsla
Etrading
Posted - 04/23/24
Wedbush Reiterates Outperform on Prime Medicine, Maintains $12 Price Target $PRME I sold this recently but i am buying back and this time planning to hold longer $spy $tsla
briefingcom
Posted - 04/23/24
$PRME: Prime Medicine to present preclinical data demonstrating broad potential of prime editing technology at upcoming scientific meetings https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240423080731PRME&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
Sandpiper22
Posted - 04/23/24
$CRBU $PRME $PSTX penny flip at your own peril